Related references
Note: Only part of the references are listed.Novel behavioural characteristics of the APPSwe/PS1ΔE9 transgenic mouse model of Alzheimer's disease
David Cheng et al.
BEHAVIOURAL BRAIN RESEARCH (2013)
Inflammation and white matter degeneration persist for years after a single traumatic brain injury
Victoria E. Johnson et al.
BRAIN (2013)
The anxiolytic effect of cannabidiol on chronically stressed mice depends on hippocampal neurogenesis: involvement of the endocannabinoid system
Alline C. Campos et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2013)
Comprehensive behavioral characterization of an APP/PS-1 double knock-in mouse model of Alzheimer's disease
Scott J. Webster et al.
ALZHEIMERS RESEARCH & THERAPY (2013)
Cognition in female transmembrane domain neuregulin 1 mutant mice
Rose Chesworth et al.
BEHAVIOURAL BRAIN RESEARCH (2012)
Cognitive phenotyping of amyloid precursor protein transgenic J20 mice
Tim Karl et al.
BEHAVIOURAL BRAIN RESEARCH (2012)
The effect of ageing on neurogenesis and oxidative stress in the APPswe/PS1deltaE9 mouse model of Alzheimer's disease
Alison Hamilton et al.
BRAIN RESEARCH (2012)
The therapeutic potential of the endocannabinoid system for Alzheimer's disease
Tim Karl et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2012)
In vivo hippocampal microdialysis reveals impairment of NMDA receptor-cGMP signaling in APPSW and APPSW/PS1L166P Alzheimer's transgenic mice
Malgorzata Duszczyk et al.
NEUROCHEMISTRY INTERNATIONAL (2012)
Distinct Neurobehavioural Effects of Cannabidiol in Transmembrane Domain Neuregulin 1 Mutant Mice
Leonora E. Long et al.
PLOS ONE (2012)
Role of Abca7 in Mouse Behaviours Relevant to Neurodegenerative Diseases
Warren Logge et al.
PLOS ONE (2012)
Phytocannabinoids as novel therapeutic agents in CNS disorders
Andrew J. Hill et al.
PHARMACOLOGY & THERAPEUTICS (2012)
Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders
Alline Cristina Campos et al.
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2012)
Plasma and brain pharmacokinetic profile of cannabidiol (CBD), cannabidivarine (CBDV), Δ9-tetrahydrocannabivarin (THCV) and cannabigerol (CBG) in rats and mice following oral and intraperitoneal administration and CBD action on obsessive-compulsive behaviour
Serena Deiana et al.
PSYCHOPHARMACOLOGY (2012)
Anxiogenic-like effects of chronic cannabidiol administration in rats
Maha M. ElBatsh et al.
PSYCHOPHARMACOLOGY (2012)
Thy1-hAPPLond/Swe+ mouse model of Alzheimer's disease displays broad behavioral deficits in sensorimotor, cognitive and social function
Mehrdad Faizi et al.
BRAIN AND BEHAVIOR (2012)
Distribution patterns of cannabinoid CB1 receptors in the hippocampus of APPswe/PS1ΔE9 double transgenic mice
Sara Kalifa et al.
BRAIN RESEARCH (2011)
Cannabidiol as an emergent therapeutic strategy for lessening the impact of inflammation on oxidative stress
George W. Booz
FREE RADICAL BIOLOGY AND MEDICINE (2011)
Palmitoylethanolamide counteracts reactive astrogliosis induced by ß-amyloid peptide
Caterina Scuderi et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2011)
Cannabidiol and Other Cannabinoids Reduce Microglial Activation In Vitro and In Vivo: Relevance to Alzheimer's Disease
Ana Maria Martin-Moreno et al.
MOLECULAR PHARMACOLOGY (2011)
Anomalies in social behaviors and exploratory activities in an APPswe/PS1 mouse model of Alzheimer's disease
Mohammed Filali et al.
PHYSIOLOGY & BEHAVIOR (2011)
Cannabidiol Reduces Ab- Induced Neuroinflammation and Promotes Hippocampal Neurogenesis through PPARγ Involvement
Giuseppe Esposito et al.
PLOS ONE (2011)
The interplay of cannabinoid and NMDA glutamate receptor systems in humans: Preliminary evidence of interactive effects of cannabidiol and ketamine in healthy human subjects
Jaime E. C. Hallak et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2011)
Cannabinoid receptor CB1 mediates baseline and activity-induced survival of new neurons in adult hippocampal neurogenesis
Susanne A. Wolf et al.
CELL COMMUNICATION AND SIGNALING (2010)
A 25-week, open-label trial investigating rivastigmine transdermal patches with concomitant memantine in mild-to-moderate Alzheimer's disease: a post hoc analysis
Martin R. Farlow et al.
CURRENT MEDICAL RESEARCH AND OPINION (2010)
A behavioural comparison of acute and chronic Δ9-tetrahydrocannabinol and cannabidiol in C57BL/6JArc mice
Leonora E. Long et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2010)
ATP-binding Cassette Transporter A1 Mediates the Beneficial Effects of the Liver X Receptor Agonist GW3965 on Object Recognition Memory and Amyloid Burden in Amyloid Precursor Protein/Presenilin 1 Mice
James J. Donkin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Functional cholinergic damage develops with amyloid accumulation in young adult APPswe/PS1dE9 transgenic mice
Eva Machova et al.
NEUROBIOLOGY OF DISEASE (2010)
Induced LC degeneration in APP/PS1 transgenic mice accelerates early cerebral amyloidosis and cognitive deficits
Daniel Jardanhazi-Kurutz et al.
NEUROCHEMISTRY INTERNATIONAL (2010)
COGNITION IN TRANSMEMBRANE DOMAIN NEUREGULIN 1 MUTANT MICE
L. Duffy et al.
NEUROSCIENCE (2010)
Cannabidiol: A Promising Drug for Neurodegenerative Disorders ?
Teresa Iuvone et al.
CNS NEUROSCIENCE & THERAPEUTICS (2009)
Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb
Angelo A. Izzo et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2009)
Cannabinoids for the treatment of dementia
Sarada Krishnan et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2009)
Inflammation and aging: Can endocannabinoids help?
Yannick Marchalant et al.
BIOMEDICINE & PHARMACOTHERAPY (2008)
Behavioural profile of a new mouse model for NPY deficiency
Tim Karl et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2008)
Memantine leads to behavioral improvement and amyloid reduction in Alzheimer's-disease-model transgenic mice shown as by micromagnetic resonance imaging
Henrieta Scholtzova et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2008)
Animal models of Alzheimer's disease and frontotemporal dementia
Jurgen Gotz et al.
NATURE REVIEWS NEUROSCIENCE (2008)
GABAA Receptor-Mediated Acceleration of Aging-Associated Memory Decline in APP/PS1 Mice and Its Pharmacological Treatment by Picrotoxin
Yuji Yoshiike et al.
PLOS ONE (2008)
Cannabidiol: from an inactive cannabinoid to a drug with wide spectrum of action
Antonio Waldo Zuardi
REVISTA BRASILEIRA DE PSIQUIATRIA (2008)
Involvement of 5HT1A receptors in the anxiolytic-like effects of cannabidiol injected into the dorsolateral periaqueductal gray of rats
Alline Cristina Campos et al.
PSYCHOPHARMACOLOGY (2008)
Cannabidiol in vivo blunts β-amyloid induced neuroinflammation by suppressing IL-1β and iNOS expression
G. Esposito et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro
A. Thomas et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Endocannabinoids and neurodegenerative diseases
Vincenzo Micale et al.
PHARMACOLOGICAL RESEARCH (2007)
Differential effects of the N-methyl-D-aspartate receptor antagonist MK-801 on different stages of object recognition memory in mice
M. Nilsson et al.
NEUROSCIENCE (2007)
The endocannabinoid system and Alzheimer's disease
Cristina Benito et al.
MOLECULAR NEUROBIOLOGY (2007)
Impaired spatial learning in the APPSwe+PSEN1ΔE9 bigenic mouse model of Alzheimer's disease
R. S. Reiserer et al.
GENES BRAIN AND BEHAVIOR (2007)
The pharmacology, neuroanatomy and neurogenetics of one-trial object recognition in rodents
Ekrem Dere et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2007)
Anxiolytic-like effect of cannabidiol in the rat Vogel conflict test
Fabricio A. Moreira et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2006)
Increased levels of 4-hydroxynonenal and acrolein, neurotoxic markers of lipid peroxidation, in the brain in Mild Cognitive Impairment and early Alzheimer's disease
Taufika Islam Williams et al.
NEUROBIOLOGY OF AGING (2006)
The marijuana component cannabidiol inhibits β-amyloid-induced tau protein hyperphosphorylation through Wnt/β-catenin pathway rescue in PC12 cells
G Esposito et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2006)
Neuroprotective effect of cannabidiol, a non-psychoactive component from Cannabis sativa, on β-amyloid-induced toxicity in PC12 cells
T Iuvone et al.
JOURNAL OF NEUROCHEMISTRY (2004)
Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil - A randomized controlled trial
PN Tariot et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Mutant presenilins specifically elevate the levels of the 42 residue β-amyloid peptide in vivo:: evidence for augmentation of a 42-specific γ secretase
JL Jankowsky et al.
HUMAN MOLECULAR GENETICS (2004)
APP processing and amyloid deposition in mice haplo-insufficient for presenilin 1
JL Jankowsky et al.
NEUROBIOLOGY OF AGING (2004)
Exploratory activity, anxiety, and motor coordination in bigenic APPswe+PS1/ΔE9 mice
R Lalonde et al.
NEUROSCIENCE LETTERS (2004)
Sociability and preference for social novelty in five inbred strains: an approach to assess autistic-like behavior in mice
SS Moy et al.
GENES BRAIN AND BEHAVIOR (2004)
Activation of microglia by secreted amyloid precursor protein evokes release of glutamate by cystine exchange and attenuates synaptic function
SW Barger et al.
JOURNAL OF NEUROCHEMISTRY (2001)
Co-expression of multiple transgenes in mouse CNS: a comparison of strategies
JL Jankowsky et al.
BIOMOLECULAR ENGINEERING (2001)
Effects of pharmacologically induced changes in NMDA-receptor activity on long-term memory in humans
TH Rammsayer
LEARNING & MEMORY (2001)
Neurobehavioral and neuropsychiatric symptoms in Alzheimer's disease - Characteristics and treatment
JA Chung et al.
NEUROLOGIC CLINICS (2000)
Share Paper
